1 Product identity
Ingredient risk
No flagged ingredients

Astaxanthin 8 mg

BrandResVitaleNon-Nutrient/Non-Botanical Capsule 9 ingredients DSLD #14095
Net contents: 60 Veggie Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2012-10-25
2 Ingredients (9)
IngredientGroupSafety
AstaPure(TM) AstaxanthinAstaxanthinGenerally Safe
Vegetarian Capsulecapsule
Soy ProteinSoy ProteinConditionally Safe
Corn StarchStarch
Rice BranRice Bran
Vegetable CelluloseCellulose
SilicaSiliconGenerally Safe
Ascorbyl PalmitateVitamin CGenerally Safe
DL-Alpha-TocopherolVitamin EConditionally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Astaxanthin — Generally Safe
⚠ May lower blood pressure
Soy Protein — Conditionally Safe
⚠ Isoflavones: estrogenic effects debated
⚠ Thyroid function may be affected
Silicon — Generally Safe
⚠ Very low toxicity
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Vitamin E — Conditionally Safe
⚠ Increased bleeding risk
⚠ All-cause mortality at >400 IU/day
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID14095
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2012-10-25
6 More from ResVitale
View ResVitale Safety Scorecard → 15 products
Brain Science With Cereboost American GinsengCollagen & Grape Seed ExtractCollagen EnhanceCollagen Enhance Burgundy BerryCollagen HydraPlump With CeramidesCollagen Renew With Vitamin C
7 Cite this page
Vancouver
Pkhakadze G. Astaxanthin 8 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 06]. Available from: https://supplement.ge/products/astaxanthin-8-mg-14095/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG